Late M&A Bonanza Stokes Healthcare Dealmakers Ahead of JPMorgan Conference

Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year. Kicking-off on Monday, the four-day JPMorgan Healthcare Conference is expected by organizers to attract over 8,000 people, including delegations from the world’s largest drugmakers. Last month alone, drugmakers including AbbVie (NYSE:ABBV), Bristol Myers (NYSE:BMY) Squibb and AstraZeneca (NASDAQ:AZN) announced roughly $25 billion worth of U.S.-listed biotech deals, according to data provider LSEG Deals Intelligence.

Read the full article: Late M&A Bonanza Stokes Healthcare Dealmakers Ahead of JPMorgan Conference //

Source: https://www.reuters.com/business/healthcare-pharmaceuticals/late-ma-bonanza-stokes-healthcare-dealmakers-ahead-jpmorgan-conference-2024-01-05

Leave a Comment

Your email address will not be published.

Scroll to Top